ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 94 filers reported holding ADURO BIOTECH INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -25.0% | 1,360 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | +100.0% | 1,360 | -9.3% | 0.00% | – |
| Q2 2019 | $2,000 | -66.7% | 1,500 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | 0.0% | 1,500 | +188.5% | 0.00% | – |
| Q3 2018 | $4,000 | -20.0% | 520 | -27.8% | 0.00% | – |
| Q2 2018 | $5,000 | -28.6% | 720 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | -96.2% | 720 | -97.1% | 0.00% | -100.0% |
| Q4 2017 | $183,000 | +1563.6% | 24,420 | +2294.1% | 0.00% | – |
| Q3 2017 | $11,000 | -8.3% | 1,020 | 0.0% | 0.00% | – |
| Q2 2017 | $12,000 | +300.0% | 1,020 | +218.8% | 0.00% | – |
| Q1 2017 | $3,000 | -57.1% | 320 | -46.7% | 0.00% | – |
| Q4 2016 | $7,000 | -74.1% | 600 | -72.7% | 0.00% | – |
| Q3 2016 | $27,000 | +8.0% | 2,200 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |